NCT03285503View on ClinicalTrials.gov

PK Study of Aripiprazole IM Depot for Chinese Patients With Schizophrenia

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

August 17, 2018

Primary Completion Date

October 14, 2019

Study Completion Date

October 14, 2019

Conditions
Schizophrenia
Interventions
DRUG

Aripiprazole IM Depot

administration of Aripiprazole IM Depot formulation at doses of 400 mg for 5 times in patients with schizophrenia.

Trial Locations (1)

100088

Beijing Anding Hospital of Capital Medical University, Beijing

Sponsors
All Listed Sponsors
lead

Otsuka Beijing Research Institute

INDUSTRY

NCT03285503 - PK Study of Aripiprazole IM Depot for Chinese Patients With Schizophrenia | Biotech Hunter | Biotech Hunter